A consecutive series of Roux-en-Y gastrojejunostomies with a mean follow-up of 11.9 years was reviewed to characterize the long-term results of patients having this operation to treat or prevent bile reflux gastritis.
Summary Background
Development of postprandial abdominal discomfort, nausea, vomiting, or bezoar formation (Roux stasis syndrome) in the postoperative follow-up period has prompted questions about the role of Roux-en-Y gastrojejunostomy to treat or prevent bile reflux gastritis.
Methods
Long-term clinical follow-up (mean, 11.9 years) data for 24 patients was collected by reviewing medical records, interviewing patients directly through telephone contact, or both. All patients who had symptoms in the follow-up period were evaluated by upper gastrointestinal series, endoscopy, or both. A modified Visick scale was used for clinical ratings.
Results
Of the 22 evaluable patients, follow-up was complete in 20; the clinical condition that prompted surgery was corrected in 21 (95%). Roux-en-Y gastrojejunostomy was successful for treating or preventing bile reflux gastritis in all 22 patients. Despite this success, clinical failure (Visick scale I l I l or IV) was documented in 8 patients (36%). Seven of the 8 patients had clinical failure within 6 months of operation, with the Roux stasis syndrome developing in 6 of them (27%).
Conclusion
This consecutive series of Roux-en-Y gastrojejunostomies performed by one surgeon has the longest follow-up to date. Although the Roux-en-Y gastrojejunostomy is safe and often successful, the procedure appears to be limited by a substantial rate of clinical dissatisfaction. Surgeons should be cautious in using it to treat primary or remedial gastrointestinal disease.
With increased use of fiber optic gastrointestinal en-tomy patients with pain and vomiting not explained by doscopy in the 1970s, a substantial number of postgas-recurrent peptic ulcer disease, anastomotic obstruction, trectomy patients had gastritis associated with bile re-or afferent loop syndrome. flux. These patients comprised a group of postgastrecIn 1897, Roux' described a technique for diverting bil- 6 Mathias and colleagues7 found delayed gastric emptying using radiolabeled meal studies and showed abnormal motor function of a Roux limb by small bowel manometry in seven patients with these symptoms. In defining this Roux Roux-en-Y gastrojejunostomy was used to prevent bile reflux gastritis in conjunction with a primary vagotomy and antrectomy for peptic ulcer disease in six patients. One patient required an incidental splenectomy because of splenic damage that occurred during the gastrectomy.
Six patients had Roux-en-Y gastrojejunostomy as part of revisional operative therapy for mechanical postgastrectomy complications. Three of them were operated on for postgastrectomy anastomotic obstruction presumed to be due to recurrent peptic ulcer disease. One of these patients had not had a previous vagotomy so this was performed during the Roux-en-Y gastrojejunostomy in conjunction with a Nissen fundoplication performed for reflux esophagitis. Two of the six patients in this group were found to have jejunogastric intussusception by upper gastrointestinal series and endoscopy. One of these two patients had not had a previous vagotomy so this was performed in conjunction with the Roux-en-Y gastrojejunostomy. In addition, this same patient also had reflux esophagitis so a Nissen fundoplication was performed. The remaining operative revision in this group was performed after resection of a benign gastrojejunocolic fistula caused by recurrent peptic ulcer disease.
Endotracheal anesthesia and a standard midline laparotomy incision were used for all patients. The gastrojejunostomy was performed using gastrointestinal stapling devices and buttressing sutures of4-0 silk at anastomotic angles. The jejunal anastomosis was placed 40 cm distal to the gastrojejunal anastomosis in all cases and also was performed using gastrointestinal staples and buttressing 4-0 silk sutures at anastomotic angles (Fig. 1) . In those patients who had revisional operation after a previous loop gastrojejunostomy (16) , the gastrojejunostomy was left intact and the afferent loop was divided by a gastrointestinal stapling device and placed 40 cm distal to the gastrojejunostomy, as previously described (Fig. 2) .
Follow-up of these patients was completed by reviewing medical records, by interviewing them through direct telephone contact, or both. All of the patients who had symptoms in the follow-up period were evaluated by upper gastrointestinal series, endoscopy, or both to rule out to IV) was documented in 8 patients (36%) ( Because of the success of biliary diversion by a Rouxen-Y gastrojejunostomy to treat postoperative bile reflux gastritis, using this technique in the anastomosis after vagotomy and antrectomy was thought reasonable to treat peptic ulcer disease and to prevent bile reflux gastritis. It also seemed logical to use the same technique in revisional gastric operations for mechanical postgastrectomy complications. Of all the patients in this series who had a Roux-en-Y gastrojejunostomy to prevent bile reflux gastritis (12) , none had bilious vomiting, bile reflux gastritis, or both.
However, in 1985, Mathias and colleagues7 defined a syndrome of chronic abdominal pain, nausea, and vomiting that was worsened with the intake of food in some patients who had a Roux-en-Y gastrojejunostomy (Roux stasis syndrome). They studied seven patients using radiolabeled solid meals to assess gastric emptying. Small bowel manometry was also used to evaluate these patients. All showed delayed gastric emptying and abnormal function of the Roux limb during the fasting state. They suggested that the Roux limb acted as a functional obstruction and may have caused the clinical symptoms.
Van der Mijle and coworkers""2 further characterized this syndrome in a larger group of patients who had Roux-en-Y gastrojejunostomy. Gastric This series confirms the effectiveness of a Roux-en-Y gastrojejunostomy used to treat or prevent bile reflux gastritis. Clinical success was achieved in all 16 of our patients for whom treatment or prevention ofbile reflux gastritis was an operative indication. However, substantial gastrointestinal symptoms and clinical dissatisfaction occurred after the Roux-en-Y gastrojejunostomy (36%) was performed. Seven of our eight clinical failures (Visick scale III to IV) occurred within 6 months of operation. Six of these patients had symptoms of the Roux stasis syndrome (27%) ( Table 4) .
Although Roux-en-Y gastrojejunostomy is safe and often successful, its use appears limited by a substantial rate of clinical dissatisfaction and surgeons should use it cautiously to treat primary or remedial gastrointestinal disease.
